Egypt-based laboratory diagnostics company Integrated Diagnostics Holdings (IDH) has completed an initial public offering (IPO) on the London Stock Exchange, facilitating a partial exit for global growth markets investor The Abraaj Group. IDH sold 65 million shares priced at US$4.45 per share, raising around US$290 million. The issue returned around US$203 million to The Abraaj Group, which sold 46 million shares in the offering. IDH is also backed by pan-emerging markets private equity firm Actis, which maintained its 21 percent stake in the company.